LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT)
Clinical trials for LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT) explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT) trials appear
Sign up with your email to follow new studies for LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lower dose of radiation plus a targeted pill treat this lymphoma just as well?
Disease control Not yet recruitingThis study is for people with a slow-growing type of lymphoma called MALT lymphoma that has not spread. It compares a very low dose of radiation (4 Gy) combined with the targeted drug orelabrutinib against the standard higher dose of radiation (24 Gy). The goal is to see if the g…
Matched conditions: LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT)
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
AI helps target stomach cancer with less harm to healthy organs
Disease control Not yet recruitingThis study tests a new way to deliver radiation for gastric MALT lymphoma. Using AI, the treatment adapts each session to better protect nearby organs. About 25 adults with early-stage disease will take part. The goal is to see if this approach is safe and effective.
Matched conditions: LYMPHOMA OF THE MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT)
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC